T he human gut microbiota (HGM) is recognized as a determinant of human health and metabolic homeostasis 1, 2 . Specific signatures of the HGM are associated with local and systemic disorders, including irritable bowel disease, obesity, type 2 diabetes and colon cancer 3 . The composition of the HGM is greatly affected by non-digestible dietary glycans 4, 5 . Only a few species of the HGM are equipped to deconstruct and ferment distinct complex glycans into short-chain fatty acids (SCFAs) 6 . The effect of SCFAs on host health and physiology remains an important aspect of the microbiota-host interaction. The SCFA butyrate, the preferred energy source for colonocytes, possesses anti-inflammatory roles and reduces the risks of colon cancer and enteric colitis [7] [8] [9] [10] . Butyrate-producing Firmicutes are abundant in healthy individuals, but are markedly reduced in patients with inflammatory disorders 11, 12 . Butyrate producers including Roseburia spp. are increased in patients with metabolic syndrome after faecal transfer therapy and correlate positively to improvement of insulin resistance 13 . Investigations of the metabolic preferences of butyrate producers and their interplay with major HGM commensals are instrumental to develop interventions targeting butyrate deficiencyrelated disorders.
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Roseburia is a common genus of Clostridium cluster XIVa within Firmicutes that harbour prevalent butyrate producers 14, 15 . This taxon adheres to mucin, reflecting intimate association with the host 16 . Roseburia intestinalis strains encode an impressive repertoire of carbohydrate-active enzymes (CAZymes) compared to most Firmicutes 17 . R. intestinalis, the taxonomically related Eubacterium rectale, and species from Bacteroides are the only known HGM taxa that utilize the hemicellulose xylan [18] [19] [20] . Xylan is particularly abundant in cereal grains (arabinoxylan) but is also found in fruits and vegetables (glucuronoxylan) 21 ( Fig. 1a) . Xylan utilization by Bacteroides-dominant gut commensals has been investigated in detail 22, 23 , but similar knowledge is lacking for Firmicutes counterparts.
Here, we show that R. intestinalis L1-82 grows on dietary-relevant xylans, with a preference for cereal arabinoxylans. The growth is mediated by a multi-modular cell-attached xylanase and by an ATP-binding cassette (ABC) transporter. We have characterized the xylanolytic enzymes and the transport protein, which enabled modelling xylan utilization by R. intestinalis and the identification of two previously undescribed xylan-specific CAZyme families. R. intestinalis efficiently competes with a model xylan degrader from Bacteroides when grown on soluble and insoluble xylans. Strikingly, transport proteins that confer xylo-oligosaccharides capture in R. intestinalis and Bacteroides targeted ligands of different sizes, thus markedly reducing the competition for preferred ligands by either taxon. These results emphasize the competitiveness of butyrate-producing Firmicutes in targeting key dietary fibres such as xylan and highlight differential glycan capture and transport as an important feature in co-growth on abundant dietary fibres such as xylan.
Results
Inducible cell-attached xylanase activity mediates growth of R. intestinalis on substituted xylans. Anaerobic growth of R. intestinalis L1-82 was measured on soluble and insoluble xylans (Fig. 1b-d) . R. intestinalis L1-82 grows rapidly on soluble xylans, especially wheat Metabolism of dietary glycans is pivotal in shaping the human gut microbiota. However, the mechanisms that promote competition for glycans among gut commensals remain unclear. Roseburia intestinalis, an abundant butyrate-producing Firmicute, is a key degrader of the major dietary fibre xylan. Despite the association of this taxon to a healthy microbiota, insight is lacking into its glycan utilization machinery. Here, we investigate the apparatus that confers R. intestinalis growth on different xylans. R. intestinalis displays a large cell-attached modular xylanase that promotes multivalent and dynamic association to xylan via four xylan-binding modules. This xylanase operates in concert with an ATP-binding cassette transporter to mediate breakdown and selective internalization of xylan fragments. The transport protein of R. intestinalis prefers oligomers of 4-5 xylosyl units, whereas the counterpart from a model xylan-degrading Bacteroides commensal targets larger ligands. Although R. intestinalis and the Bacteroides competitor co-grew in a mixed culture on xylan, R. intestinalis dominated on the preferred transport substrate xylotetraose. These findings highlight the differentiation of capture and transport preferences as a possible strategy to facilitate co-growth on abundant dietary fibres and may offer a unique route to manipulate the microbiota based on glycan transport preferences in therapeutic interventions to boost distinct taxa.
Genes encoding an ABC transporter and a multi-modular xylanase are top upregulated in response to growth on xylan. We performed an RNA sequencing (RNA-seq) transcriptional analysis of R. intestinalis grown on WAX, BGX, xylose and glucose. Of the 4,777 predicted genes, 1-3.5% were highly upregulated (log 2 fold change > 5) on xylans compared to glucose (Supplementary  Table 1 ) and the majority were involved in carbohydrate metabolism. Besides a separate locus encoding a multi-modular xylanase of glycoside hydrolase family 10 (GH10 according to CAZy classification 24 ), the top genes in the xylan transcriptomes cluster on a single locus (Fig. 2a,b ) that contains 11 genes, including 4 xylanolytic CAZymes: GH43, GH115, GH8 and GH3. Only one (ROSINTL182_08192, LacI type) of three transcriptional regulators was highly upregulated. Strikingly, the most upregulated gene in the xylan transcriptomes encodes a solute-binding protein (SBP) of an ABC transporter. The permease genes of this transporter were among the top six upregulated by xylans. Signal peptides were only predicted for the xylanase and the transporter SBP, which is consistent with the extracellular breakdown of xylan followed by capture and uptake of xylo-oligosaccharides by the ABC transporter. The expression and the localization of the SBP and the xylanase at the cell surface were corroborated using immunofluorescence microscopy (Fig. 2c) . Two additional loci, unique to the R. intestinalis L1-82 strain, were also upregulated albeit markedly less ( Supplementary  Fig. 1a-d) . One of these loci encodes a second active GH10 xylanase, which is expressed at the cell surface ( Supplementary Fig. 1e ). The transcriptomic analyses enabled the assignment of the xylose ABC transporter and the genes involved in intracellular metabolism of xylose, arabinose and glucuronic acid ( Supplementary Fig. 2) .
A previously undescribed family of binding modules confers extended and dynamic xylan binding to the multi-modular xylanase. The highly upregulated RiXyn10A, which is conserved within R. intestinalis ( Supplementary Fig. 3 ), is one of the largest known xylanases from the HGM (Supplementary Table 2 ). RiXyn10A comprises an amino-terminal unassigned domain (residues 28− 165), a CBM22 xylan-binding module, a GH10 catalytic module, two tandem CBM9 xylan-binding modules, a bacterial immunoglobulin-like Relative activity (%) deviations. e, Xylanase activity of R. intestinalis cells grown on glucose, xylo-oligosaccharides, BGX and WAX for 18 hours. f, Cells grown on BGX were washed (PBS buffer ± 1.5 M NaCl) and xylanase activity was measured in wash and cell fractions to verify the localization of the enzymes. Xylanase activity (e,f) was measured using the DNS-reducing sugar assay, and data are triplicates with standard deviations.
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domain group 2 (pfam02368) 25 and a Listeria-Bacteroides repeat domain (pfam09479) 26 . The two latter positively charged domains (residues 1,100-1,356; pI > 10) (Fig. 3a) probably mediate attachment of the enzyme to the cell [25] [26] [27] . RiXyn10A incubated with BGX, WAX and InWAX generated linear and decorated oligosaccharides (Fig. 3b,c) , but was inactive on highly and heterogeneously substituted arabinoglucuronoxylan from corn bran, consistent with the growth profile (Fig. 1b) . The enzyme was inactive on X2 and showed poor activity on xylotriose (X3) (Supplementary Fig. 4a ). Xylotetraose (X4) and xylopentaose (X5) were efficiently hydrolysed, revealing the requirement for the occupancy of at least four substrate-binding subsites for high turnover.
A BLASTp search of the N-terminal domain (previously undescribed carbohydrate-binding module (CBMx)) against UniProt gave no hits indicating the lack of homologues with assigned function. CBMx confers affinity to xylan based on a two-times higher Michaelis constant (K m ) when CBMx was deleted from RiXyn10A showing the extracellular localization of RiXBP and RiXyn10A, the SBP of the xylo-oligosaccharide-specific ABC transporter and the xylanase, respectively, were visualized by fluorescence microscopy of R. intestinalis cells in biological triplicates using primary antibodies against these two proteins.
Nature Microbiology (Table 1 and Supplementary Fig. 4b-g ). Affinity electrophoresis established CBMx as a xylan-binding module and revealed a 30-fold higher dissociation constant (K d ) on WAX compared with BGX ( Fig. 3d-f and Supplementary Fig. 4h ). Surface plasmon resonance (SPR) analysis revealed the highest affinity towards xylohexaose (X6) ( Table 2 , Fig. 3g and Supplementary Fig. 5a -e). The relatively low binding affinity to X6 (K d ≈ 0.5 mM) was corroborated using isothermal titration calorimetry (ITC) ( Table 4 ).
Preference of the binding protein of the ABC transporter that mediates uptake of xylo-oligosaccharides. Complex xylooligosaccharides decorated with arabinosyl and 4-O-methylglucuronosyl are produced by RiXyn10, based on the decrease levels in some of these products and the increase levels in arabinose, 4-O-methyl-glucuronic acid (MeGlcA) and un-substituted xylo-oligosaccharides after treatment with debranching enzymes (see the next section). Transcriptional analysis (Fig. 2a) identified a 
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Ri Xyn10A Articles Nature Microbiology plausible ABC transporter of xylo-oligosaccharides. The preference of SBPs associated with oligosaccharide-specific ABC transporters correlates with the bacterial uptake preference 28, 29 . We measured the affinity of RiXBP, the SBP of the top upregulated ABC transporter on xylo-oligomers (Table 3 and Supplementary Fig. 6a-i) . The preferred un-substituted ligand was X5 followed by X4, and the affinity decreased steeply for smaller or larger oligosaccharides. Internal arabinosyl decorations (AX4) were preferred based on the 2.4-times higher affinity compared to X4. The tolerance and recognition of arabinosylated ligands are supported by the good growth on WAX. In summary, RiXBP is selective in capturing branched xylo-oligosaccharides with preference for a backbone of 4− 5 xylose residues.
The concentrations of oligosaccharides in spent supernatants from R. intestinalis cultures during growth on xylan were too low for reliable detection using high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD), which suggests an efficient uptake of oligomeric products ( Supplementary Fig. 6j ,k).
R. intestinalis degrades internalized decorated xylo-oligosaccharides by the concerted action of three hydrolases and a previously undescribed family of acetyl esterases. Xylo-oligosaccharides are degraded in the cytoplasm after uptake. We characterized the α -glucuronidase RiAgu115A (GH115), the α -l-arabinofuranosidase RiAbf43A (GH43), two xylosidases RiXyl8 (GH8) and RiXyl3A (GH3) as well as RiAXE (ROSITNL182_08194; GenBank accession EEU99941.1) from the core xylan utilization locus.
RiAgu115A released MeGlcA from glucuronoxylans (BGX and beechwood glucuronoxylan) and from BGX pretreated with RiXyn10A (Fig. 4a ,c-f and Supplementary Fig. 7a ). The k cat /K m of RiAgu115A was 16-fold higher on glucuronoxylan hydrolysate compared to intact glucuronoxylan (Supplementary Table 5 ), consistent with the intracellular enzyme localization. This enzyme also cleaves MeGlcA decorations at the xylosyl penultimate to the reducing end ( Supplementary Fig. 7b ,c), but its activity was blocked by acetylations (Fig. 4d) . The released MeGlcA is metabolized intracellularly in agreement with the transcriptomic data ( Supplementary  Fig. 2a ). The lack of growth on glucuronic acid (Fig. 1b) is probably due to the lack of an uptake system for this monosaccharide.
RiAbf43A is an α -l-arabinofuranosidase that exclusively releases arabinose from WAX ( Fig. 4a and Supplementary Fig. 7d ). Kinetic analysis against WAX and AX4 (Supplementary Table 6 ) revealed recognition of internal arabinosyl substitutions. Degradation of WAX by xylanases results in the production of significant amounts of double-arabinosyl-substituted oligomers. The lack of accumulation of these to detectable levels ( Supplementary Fig. 6j ) is suggestive of their uptake and debranching by RiAbf43A or other upregulated arabinofuranosidases.
Both RiXyl3A and RiXyl8 generated xylose from xylo-oligosaccharides, but lacked activity towards xylan (Supplementary Tables  7,8 and Supplementary Fig. 7d-g ). RiXyl3A degraded xylo-oligosaccharides to xylose, whereas RiXyl8 was inactive towards X2. Reduction of xylo-oligosaccharides abolished the activity of RiXyl8, assigning it as a reducing-end β -xylosidase 30 ( Supplementary Fig.  7h ), in contrast to RiXyl3A that recognizes non-reducing xylosyl units. The concerted and overlapping activities of these enzymes ( Supplementary Fig. 7 ) result in rapid depolymerization of arabinosyl-and MeGlcA-decorated xylo-oligosaccharides. Induction of extracellular xylanase activity by X2, but not by X3− X6, is intriguing as X2 is transiently formed during cytoplasmic degradation of X3− X6. A possible explanation is that the induction is mediated by X2 binding to an extracellular regulatory protein, similar to the xylose sensory system in clostridial Firmicutes 31 . RiAXE, which lacks functionally described homologues, was highly upregulated on xylans (Fig. 2a) . This enzyme shares conserved residues with the SGNH lipase esterase superfamily (Pfam cd00229), but possesses low sequence identities to esterases from CAZy. Homologues of this enzyme are encoded by Clostridium cluster XIVa strains from the human gut and a range of Firmicutes ( Supplementary Fig. 8a ). Assaying RiAXE activity towards acetylated BGX (AcBGX) oligosaccharides (generated with RiXyn10A) using NMR revealed efficient deacetylation of both 2-O-acetylated xylose (C2) and 3-O-acetylated xylose (C3), but with a preference for C2 decorations (Fig. 4b, Supplementary Tables 9,10 and Supplementary Fig. 8 ). RiAXE left a single acetyl group on the AcBGX oligosaccharides (Fig. 4e) . Inclusion of RiAgu115A in this reaction resulted in complete deacetylation (Fig. 4f) , suggesting that close MeGlcA decorations protect closeby acetylations. Analysis of the deacetylation rates unveiled the concerted action with RiAgu115A and preference to hydrolysates of RiXyn10A rather than intact xylan ( Supplementary Fig. 8b,c) . RiAXE specifically recognizes acetylations on xylosyl units based on the lack of activity on acetylated chitin and very low activity on acetylated mannan and cellulose monoacetate (Supplementary Table 11 ). Accordingly, RiAXE is an efficient xylan-specific representative of a previously undescribed acetyl esterase family. Binding energetics of the transport protein RiXBP to xylo-oligosaccharides determined by ITC. Data are the means of duplicate experiments. N 0 , Δ H, TΔ S and Δ G denote the binding stoichiometry, enthalpy, entropy and Gibbs free energy, respectively. ND indicates affinity too low to be determined. The cartoons to the right side depict the analysed susbtrates using the same code as in Fig. 1a , and the chemical structures of arabinosyl-decorated oligomers AX3 and AX4 are shown in Supplementary Fig. 6h ,i.
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In summary of the biochemical characterization presented above, we propose a model for the uptake and degradation of dietderived acetylated arabinoxylan and glucuronoxylan by R. intestinalis L1-82 (Fig. 5a ).
R. intestinalis competes with Bacteriodes for xylans. The growth potential of R. intestinalis was compared to the efficient xylandegrader Bacteroides ovatus 22 , by observing the growth of individual cultures and in co-culture. Both strains displayed similar growth on xylan as a carbon source (Fig. 5b-d and Supplementary Fig.  9a,b) . In competition, both strains appeared to grow well on xylans, whereas R. intestinalis dominated the co-culture on X4 after 7 hours of growth (Fig. 5e-h) . The results indicate that R. intestinalis is an efficient primary degrader of xylan that is able to compete with B. ovatus and outcompete this bacterium on preferred smaller xylooligosaccharides.
Discussion
The human gut is dominated by bacteria from the Firmicutes and Bacteriodetes phyla. Firmicutes are regarded as metabolic specialists, whereas Bacteroidetes (mainly Bacteroides) are considered generalists based on narrow versus broad glycan utilization capabilities, respectively 6 . The size and diversity of encoded CAZymes reflect these metabolic labels, which applies to R. intestinalis, based on the limited glycan growth profiles 5 . However, this species possesses distinctively larger CAZymes than most known gut clostridial Firmicutes 17 . R. intestinalis has been proposed to be a key xylan degrader in the human gut along with specific species of Bacteroides 18, 19 . Enumeration of R. intestinalis on xylans including wheat bran is reported in vitro and in vivo 20, 32 . However, insight is lacking on the preferences and the molecular machinery evolved by R. intestinalis to target xylan compared to Bacteriodes members. In this study, we present a model underpinning the molecular basis ovatus. a, RiXyn10A on the cell surface efficiently captures dietderived acetylated arabinoxylan and acetylated glucuronoxylan by its CBMs and hydrolyses it into linear and decorated xylo-oligosaccharides, which are subsequently captured by RiXBP for uptake into the cytoplasm. Internalized xylo-oligosaccharides are debranched and hydrolysed into monosaccharides and acetate. Xylose and arabinose are converted to xylulose 5-phosphate before entering the pentose phosphate pathway, whereas MeGlcA is converted to 2-oxo-3-deoxygalactonate 6-phosphate. These precursors enter glycolysis, which generates pyruvate, some of which is converted to butyrate 54 . The asterisk next to RiAbf43A indicates activity on both α -1,2-linked and α -1,3-linked l-arabinose. The black solid arrows show steps established or confirmed in this study. The grey solid arrows indicate steps for the production of H 2 and butyrate by R. intestinalis 15 , which has been demonstrated for this species during xylose fermentation 19 . The grey dashed arrows indicate that H 2 and butyrate are externalized by unknown mechanisms. To make the model more general for the R. intestinalis species, the second less upregulated extracellular xylanase RiXynB, which is unique for the L1-82 strain, is not included in the model, although it is expressed at the cell surface. 
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for xylan utilization by R. intestinalis L1-82 as a representative for prevalent butyrate-producing clostridia (Fig. 5a ). R. intestinalis is a primary degrader equipped with a highly efficient machinery for the utilization of complex dietary xylans, including insoluble arabinoxylan from cereals. Key components of the R. intestinalis xylan utilization strategy include a multi-modular extracellular xylanase and an ABC transporter, which confer the capture, breakdown and internalization of decorated xylo-oligosaccharides. In the cytoplasm, internalized oligomers are degraded without loss to competing species. R. intestinalis grows on acetylated xylan, which reflects an adaptation to this abundant decoration in dietary xylans (Fig. 1b) . Internalized acetylated xylo-oligosaccharides are metabolized by an intracellular previously unknown esterase family that is capable of removing C2, C3 and double acetylations (Fig. 4b and Supplementary Fig. 8 ).
The extracellular xylanase RiXyn10A, the ABC transporter and enzymes conferring cytoplasmic breakdown of xylan oligosaccharides were assigned as the core xylan utilization apparatus of R. intestinalis (Fig. 2a,b) . This was based on (1) conservation of this apparatus within this species (Supplementary Fig. 3 ), (2) the highest transcriptional upregulation (Fig. 2a) , and (3) biochemical data from the present study. The two additional xylan-upregulated loci in R. intestinalis L1-82 ( Supplementary Fig. 1 ) are lacking in the xylanutilizing R. intestinalis XB6B4 and R. intestinalis M50/1 (ref. 20 ). The expression and activity of the xylanase RiXyn10B, encoded by an auxiliary locus (Supplementary Table 12 and Supplementary  Fig. 1c,e) , supports the participation of more than one locus in xylan breakdown in R. intestinalis L1-82. Multiplicity of xylan utilization loci is implicated in targeting a larger structural diversity of naturally occurring xylans by Bacteroides 22 , which may also apply for R. intestinalis.
The R. intestinalis core xylanase RiXyn10A mediates the capture and breakdown of arabinoxylan and glucuronoxylan (Figs. 1,3 ). This enzyme possesses four CBMs from two known and one previously undescribed xylan-binding families, representing the most complex organization of HGM xylanases ( Fig. 3a and Supplementary Table 2 ). This organization is conserved within currently sequenced R. intestinalis species, whereas other Clostridium XIVa taxa possess simpler enzymes that lack one or more of the RiXyn10A CBMs. The N-terminal CBMx of RiXyn10A displays approximately 7-fold lower affinity for X6 than the average affinity measured for the enzyme variant lacking this module (Table 2) . Nonetheless, CBMx is selective for arabinoxylan and contributes to the overall affinity of the enzyme (Table 1) . Low-affinity CBMs may potentiate multivalent cooperative substrate binding, with less reduction of k cat (that is, promote relatively high k cat /k off 33 ), compared to higher-affinity counterparts that evoke higher energetic penalty during substrate displacement. The extended binding mediated by the CBMs seems to confer an advantage in the capture and prolonged contact of the enzyme with xylan. Deletion of the CBMs (RiXyn10A-cata) caused a substantial decrease in the apparent affinity towards WAX and BGX and deviation from Michaelis-Menten kinetics (Table 1 and Supplementary Fig. 4b-g ). These findings are consistent with the importance of CBMs in catalysis under substrate limitations, whereas similar turnover rates were obtained by the catalytic module and the full-length RiXyn10A at high (9 mg ml −1 ) substrate concentrations. Multiplicity and variability of CBMs seem to be a signature of extracellular enzymes from butyrate-producing Firmicutes 34, 35 . By contrast, Bacteriodes members possess simpler xylanases with an inserted tandem CBM4 repeat within the catalytic module 23 . However, xylan capture by Bacteriodes is additionally orchestrated by moderate-affinity (K d ≈ 60 µ M) binding proteins 22 . R. intestinalis was able to compete with B. ovatus for xylans during the log-phase (Fig. 5e-g ). Notably, R. intestinalis seemed to outcompete B. ovatus after propagation of the co-culture (in the late log phase) in fresh medium for two additional passages, underscoring the competitiveness of the xylan utilization machinery of this Firmicute (Supplementary Fig. 9c ). R. intestinalis association to insoluble xylans, including wheat bran was reported, whereas Bacteriodes spp. were enriched in solubilized xylan fractions 18, 36 . The extended binding by RiXyn10A may have an important role in the association to insoluble substrates. Indeed, the expression of this enzyme seemed similarly high in the mono-and mixed xylan cultures with B. ovatus ( Supplementary Fig. 9e ), in contrast to the reported downregulation of hydrolases by the taxonomically realted E. rectale during co-growth with Bacteriodes thetaiotamicron on a fibre-rich diet in mice 37 . The gene encoding the binding protein (RiXBP) of the ABC transporter that confers xylo-oligosaccharide uptake in R. intestinalis was the most upregulated in the xylan transcriptomes, attesting the crucial role of oligosaccharide capture and transport in the densely populated gut ecological niche. The affinity and size preference of RiXBP were found to be very different from the corresponding protein from Bifidobacterium 29 , which prefers shorter xylo-oligosaccharides with a different side-chain decoration pattern. Importantly, striking differences in binding affinities and preference are observed when RiXBP is compared to the SusD-like xylan-binding counterpart from Bacteriodes. Indeed, both SusDlike proteins from B. ovatus, which mediate the capture and internalization of xylo-oligosaccharides ≥ X6 by SusC TonB-dependent permeases, displayed no measurable binding to X4 and X5 (ref. 22 ), the preferred ligands of RiXBP (Table 3 ). These differential transport protein preferences are likely to be instrumental in establishing competitive uptake profiles to select oligosaccharides of specific sizes and decorations for each taxon. This is supported by the dominance of R. intestinalis when the co-culture with B. ovatus was grown on X4 (Fig. 5h) .
Our study highlights the molecular apparatus that R. intestinalis, as a model Clostridium group XIVa Firmicute, has evolved to compete for abundant dietary glycans with other dominant commensal bacteria. Strikingly, complex enzymes with multiple ancillary modules mediate multivalent substrate capture and breakdown. Highly expressed ABC transporters mediate efficient capture and uptake of xylan oligosaccharides with a different preference than the corresponding transport systems of currently known competing taxa. These findings suggest that the differentiation of glycan capture and uptake preferences may contribute to co-growth on dietary fibres by establishing competitive windows for distinct fibre breakdown oligomers by different taxa. Our study sets the stage for further investigations to evaluate the generality of this hypothesis.
Methods
Chemicals. All chemicals were of analytical grade. BGX, beechwood glucuronoxylan, corncob xylo-oligosaccharides and xylose were from Carl Roth (Karlsruhe, Germany). CBX was a kind gift from M. Yadav (US Department of Agriculture, Agricultural Research Service). Soluble wheat arabinoxylan (low viscosity: 10 centiStokes (cSt)) (WAX), insoluble wheat arabinoxylan (high viscosity: 48 cSt) (InWAX), xylobiose through to xylohexaose (X2− X6), arabinoxylotriose (AX3), arabinoxylotetraose (AX4) and mannohexaose (Man6) were from Megazyme. d-Glucuronic acid was from Sigma-Aldrich. l-Arabinose was from VWR International. Xylo-oligosaccharides Longlive 95 P (XOS) were from Shandong Longlive Bio-technology. AcBGX, acetylated aspen glucuronoxylan and acetylated spruce galactoglucomannan were prepared with steam explosion as previously described 38 . Cellulose acetate was a kind gift from A. Deutschle (University of Hamburg, Germany). Acetylated chitin-oligosaccharides were prepared as previously described 39 .
Growth experiments and RNA-seq transcriptional analysis. R. intestinalis DSM 14610 was grown in a Whitley DG250 Anaerobic Workstation (Don Whitley Scientific) in YCFA medium 14 supplemented with autoclaved-sterilized 0.5% (w/v) carbohydrates. Cultures (5 ml) were grown in triplicates, and optical denisty at 600 nm (OD 600 ) and pH (for insoluble substrates) were measured to assess bacterial growth until the stationary phase was reached. Growth rates were calculated from the exponential growth phase.
For the RNA-seq analysis, total RNA was extracted at mid-to late-log phase (OD 600 = 0.5− 0.7) from biological triplicate cultures (10 ml) grown in YCFA Nature Microbiology supplemented with 0.5% (w/v) glucose, xylose, WAX or BGX. Cells were harvested (4,000g for 5 min at room temperature) and the pellets were frozen at − 80 °C until RNA extraction. The RNA was extracted using the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol after enzymatic lysis followed by mechanical disruption of the cells. A DNase treatment was included to ensure removal of DNA. The purity and quantity of the extracted RNA were assessed by an Agilent 2100 Bioanalyzer (Agilent Technologies). Removal of ribosomal RNA and library construction for RNA-seq were performed using the ScriptSeq Complete Kit (Epicentre). High-throughput sequencing was performed in a single lane in paired-end reads on an Illumina Hiseq 4000 platform at Beijing Genomics Institute (BGI). In total, 400 million paired-end reads were obtained and the read quality was assessed by FastQC v0.11.5 (http://www.bioinformatics.babraham. ac.uk/projects/fastqc/). The R1 reads were chosen for downstream analysis. Adaptor trimming and de-multiplexing were performed using custom python scripts (based on the Biopython SeqIO module 40 ) and the FASTX-Toolkit v0.0.13.2 (http://hannonlab.cshl.edu/fastx_toolkit/). Reads were further trimmed with fastx_ trimmer and subsequently filtered with fastq_quality_filter with minimum quality score of 30 (-q 30), where 95% of base pairs (bp) meet the minimum quality score (-p 95). The resulting reads were kept if they were longer than 20 bp (-m 20) . The R. intestinalis L1-82 reference genome and genome annotations are based on assembly GCA_000156535.1_ASM15653v1, obtained from the NCBI (ftp:// ftp.ncbi.nlm.nih.gov/genomes/genbank/bacteria/Roseburia_intestinalis/). Reads were mapped to the reference genome using Tophat2 (refs 41, 42 ), and gene counts were determined with HTseq 43 . Differential gene expression was performed using DeSeq2 in R 44 .
Xylanase activity measurements on whole cells. Cell-associated xylanase activity was determined by growing R. intestinalis cells in 800 µ l YCFA containing 0.5% (w/v) xylo-oligosaccharides, WAX, BGX or glucose for 15 h. Cells were harvested (4,000g for 5 min at room temperature), resuspended in PBS to OD 600 = 0.3 and xylanase activity was assayed using the 3,5-dinitrosalicylic acid (DNS) assay as described below. To determine the effect of high ionic strength on the localization of xylanase activity, R. intestinalis cells were grown in 6 ml YCFA containing 0.5% (w/v) BGX for 15 h. Subsequently, the culture was divided into two 3 ml aliquots and harvested as described above. Cell pellets were resuspended in 300 µ l PBS with or without 1.5 M NaCl. The suspensions were spun down and both pellets and supernatants (wash fractions) were collected. Cell pellets were washed with excess PBS and resuspended in 300 µ l PBS. The xylanase activity of cells and wash fractions was assayed using the DNS assay.
Expression and purification of R. intestinalis proteins mediating xylan utilization. Open reading frames of the proteins without signal peptide, as predicted by SignalP v.3.0 (http://www.cbs.dtu.dk/services/SignalP-3.0), were amplified from R. intestinalis DSM 14610 genomic DNA using specific primers (Supplementary Table 13 ). Amplicons were cloned into the EcoRI and NcoI restriction sites of a pETM-11 (a kind gift from G. Stier, EMBL, Center for Biochemistry, Heidelberg, Germany) 45 or the XhoI and NcoI restriction site of a pET28a(+ ) (Novagen) using In-Fusion cloning (Takara) to express proteins as fusions with either cleavable N-terminal His 6 tags or C-terminal His 6 tags, respectively. Standard protocols were used for recombinant protein expression and purification using His-affinity and size-exclusion chromatography.
Enzymatic activity assays. Enzymatic assays were carried out in a 50 mM HEPES 0.005% (v/v) Triton X-100, pH 7.0 standard assay buffer unless otherwise stated. Hydrolysis kinetics of full-length or truncated xylanases (10− 200 µ M) were assayed towards 1− 9 mg ml −1 of BGX, WAX or InWAX (900 µ l at 37 °C for 12 min). Initial hydrolysis rates were determined by removing 200 µ l aliquots every 3 min and quenching the reaction in 300 µ l DNS reagent 46 . Next, samples were incubated for 15 min at 90 °C followed by absorbance at 540 nm (A 540 ) measurement in 96-well microtitre plates. Xylose was used as a standard (0− 2.5 mM). Xylanase activity was assayed for R. intestinalis cells washed with PBS ± 1.5 M NaCl, and wash fractions, as above with the following modification: 180 µ l of 1% (w/v) BGX was incubated with 20 µ l cell suspension or wash fraction for 4 h.
Hydrolysis kinetics of α -glucuronidase were analysed on 1− 9 mg ml
beechwood glucuronoxylan or a hydrolysate thereof (prepared by incubation with 4 mM RiXyn10A xylanase for 15 h at 37 °C followed by heat inactivation). The initial rates of MeGlcA release were measured using a coupled enzymatic assay (Megazyme). Reactions (770 µ l) were incubated for 2 min at 37 °C with 10− 180 nM enzyme with intermittent removal of 175 µ l aliquots every 15 s into 125 µ l 1 M Tris pH 10 to quench the reaction. This was followed by mixing 270 µ l of the stopped reaction with 45 µ l of the NAD + and uronate dehydrogenase reagents. Conversion of NAD + to NADH was measured at A 340 . Glucuronic acid was used as standard (0− 500 µ M).
Hydrolysis kinetics of RiXyl8 and RiXyl3A were determined towards X2 through to X6 (0.5-12 mM) in McIlvaine buffer pH 6.8 (10 mM citric acid and 20 mM sodium phosphate) as described previously 47, 48 . Reactions (350 µ l) were incubated for 12 min at 37 °C with 36− 78 nM RiXyl3A or 2.4 nM RiXyn8. Aliquots of 50 µ l were removed every 2 min and stopped in 250 µ l p-bromoaniline (2% w/v) in glacial acetic acid with thiourea (4% w/v). The stopped reactions were incubated in darkness for 10 min at 70 °C, followed by incubation at 37 °C for 1 h before measuring A 520 . The concentration of released pentoses was determined using a xylose standard (0− 5 mM) 49 . α -l-Arabinofuranosidase activity for RiAbf43A was assayed in McIlvaine buffer pH 6.8 (10 mM citric acid and 20 mM sodium phosphate) using a coupled enzymatic l-arabinose/d-galactose assay (Megazyme) towards WAX (1− 24 mg ml −1 ). Reactions (75 µ l) were incubated for 12 min at 37 °C with 0.4− 1.7 µ M enzyme. Aliquots of 15 µ l were removed every 2 min, and the enzyme was inactivated (10 min at 90 °C) and thereafter 10 µ l of this solution were mixed with 10 µ l of the provided NAD + , 20 µ l of provided assay buffer and 2 µ l galactose mutaotase/β -galactose dehydrogenase mix. The formation of NADH was measured as above. Arabinose was used as standard (0− 5 mM).
The acetyl esterase-specific activity of RiAXE was determined in 250 µ l reactions containing para-nitrophenyl-acetate (4 mM) and 0.14 µ M enzyme. A 405 was measured every 60 s for 10 min at 37 °C in a microtitre plate reader and pNP (0− 1 mM) was used as standard. The specific activity was determined in units (U) per mg, where a U is defined as the amount of enzyme that produces 1 µ mol of pNP min −1 . Kinetic parameters were calculated by fitting the Michaelis-Menten equation to the initial rate data using GraphPad Prism 7. The catalytic efficiency k cat /K m , determined from the slope of the normalized initial rate (V 0 /[E]) in the MichaelisMenten plot, is reported when saturation was not attained. All experiments were performed in triplicates.
Action patterns of individual and mixtures of xylanolytic enzymes.
Hydrolysis of xylan and xylo-oligosachharides was performed at 37 °C for 15 h in the standard assay buffer used above. Oligosaccharide hydrolysates, used to assay the sequential action of the debranching xylanolytic enzymes, were generated using RiXyn10A, which was separated by ultrafiltration (3 kDa cut-off) before the addition of debranching enzymes. The hydrolysis profiles were analysed as detailed below. To verify the mode of reducing-end attack of RiXyl8, 30 mg XOS in standard assay buffer were reduced by NaBH 4 (1 M in 100 µ M NaOH). A total of 200 µ l of the NaBH 4 was added dropwise to 800 µ l of the xylo-oligossaccharides solution, which was kept on ice. As a control, 100 µ M NaOH was added to an 800 µ l xylooligossaccharides solution. The mixture was incubated for 1 h at room temperature, then quenched by 400 µ l 1 M acetic acid and diluted 10× in assay buffer. The recorded spectrum is a pseudo-two dimensional (2D)-type experiment recording a 1D proton NMR spectrum every 5 min with in total 220 time points. The 1D proton spectrum was recorded with 24 scans using a 30° flip angle and a relaxation delay of 1 s (total recording time of 73 s). For enzyme treatment, 2.5 µ l of RiXyn10A and RiAgu115A were added to the AcBGX sample to 167 nM and 13 nM, respectively, and the sample was incubated at 37 °C for 24 h prior to RiAXE addition. All homonuclear and heteronuclear NMR experiments were recorded on a BRUKER AVIIIHD 800 MHz (Bruker BioSpin) equipped with 5 mm with cryogenic CP-TCI, and all acquisitions were done at 37 °C. For the chemical shift assignment of AcBGX, the following spectra were recorded: 1D proton, 2D doublequantum-filtered correlation spectroscopy (DQF-COSY), 2D total correlation spectroscopy (TOCSY), 2D
13 C-heteronuclear single-quantum coherence (HSQC), 2D . The spectra were recorded, processed and analysed using TopSpin 3.5 software (Bruker BioSpin).
SPR.
Xylo-oligosaccharide binding to RiXyn10A, RiXyn10AΔ CBMx and RiXyn10A-CBMx was analysed using SPR on a BIAcore T100 (GE Healthcare). Immobilization of the proteins on a CM5 chips was performed using a random amine coupling kit (GE Healthcare) according to the manufacturer's protocol with 50-150 µ g ml −1 protein in 10 mM sodium acetate pH 3.6-4.2, to a density of 1,362, 10,531 and 4,041 response units (RU) for RiXyn10A∆ CBMx, RiXyn10A and RiXyn10A-CBMx, respectively. The analysis comprised 90 s of association and 240 s of dissociation at 30 µ l min −1
. Sensograms were recorded at 25 °C in 20 mM phosphate/citrate buffer (pH 6.5), 150 mM NaCl and 0.005% (v/v) P20 (GE Healthcare). Solutions were filtered prior to analysis (0.22 μ m). Experiments were performed in duplicates with seven concentrations in the range: 156 µ M-10 mM for X3, 75 µ M-4 mM for X4, X6 and Man6 and 62.5 µ M-4 mM for X5. Data analysis was carried out using the Biacore T100 evaluation software, and K d were determined by fitting a one-binding site model to the steady-state sensograms.
ITC.
Titrations were performed using a Microcal ITC200 calorimeter (GE Healthcare) at 25 °C with RiXBP (0.1 mM) or RiXyn10A∆ CBMx (0.25 mM) in the sample cell and xylo-oligosaccharides (2.2-5 mM) in 10 mM sodium phosphate pH 6.5 in the syringe. An initial injection of 0.5 µ l was followed by 19 × 2 µ l injections separated by 120 s. The data were corrected for the heat of dilution, determined from buffer titration and a non-linear single-binding model was fitted to the normalized integrated binding isotherms using the MicroCal Origin software v7.0 to determine the binding thermodynamics.
Affinity electrophoresis.
Binding of CBMx to WAX (0− 0.1% w/v) or BGX (0− 1.0% w/v) was assessed by affinity electrophoresis 52 in 10% native polyacrylamide gels (70 V for 3 h at 4 °C) using purified recombinant RiXyn10A-CBMx (3.0 µ g) and β -lactoglobulin (1.5 µ g) as a negative control. The relative mobility (r) was calculated as the migration of RiXyn10A-CBMx relative to migration of the dye front. A linear regression of the 1/r versus xylan concentration allowed the determination of K d as the intercept of this x axis.
Western blot and immunofluorescence microscopy. Custom antibodies against the recombinant for the two xylanases RiXyn10A, RiXyn10B and the transport protein RiXBP were raised in rats and rabbit, respectively (Eurogentec). The specificity of the antibodies was tested by western blots using a standard protocol. The membranes were blocked for 1 h in 1% (w/v) BSA in TBST buffer (Trisbuffered saline, 0.1% (v/v Tween 20)) and incubated for 2 h with the anti-sera (500× dilution in TBST-buffer). Subsequently, the membranes were washed three times in TBST buffer and incubated for 2 h with 6,000× diluted secondary polyclonal goat anti-rabbit IgG-AP antibodies coupled to alkaline phosphatase (AP) (Dako) and rabbit anti-rat IgG-AP (Sigma). After three washes, the proteins were visualized by exposure to Sigma-Fast BCIP/NBT reagent (Sigma).
R. intestinalis cells were grown in 6 ml YCFA containing 0.5% (w/v) WAX to OD 600 ≈ 0.8, harvested (4,000g for 5 min at room temperature) and washed twice in PBS. The cells were resuspended in 3 ml 4% (w/v) paraformaldehyde in PBS and fixed by incubation on ice for 15 min. Thereafter, the cells were washed twice in PBS and resuspended in 2 ml PBS. 50 µ l of cell suspension were added to glass slides coated with poly-l-lysine, cells were blocked for 1 h in blocking buffer (1% (w/v) milk powder in PBS) and washed twice in PBS. For labelling, the cells were incubated with 50 µ l anti-sera diluted 50× in blocking buffer for 2 h, washed twice in PBS and incubated for 1 h with 50 µ l goat anti-rat IgG Alexa-Flour 555 or goat anti-rabbit IgG Alexa-Flour 488 (Thermo Scientific). Secondary antibodies were diluted 500× PBS. Finally, cells were washed twice in PBS, one drop of ProLong Gold antifade (Thermo Scientific) was applied and the cells were secured with a cover slide. Fluorescence was visualized using Zeiss Axioplan 2 microscope equipped with a CoolSNAP cf color camera and a Zeiss Plan-Neofluar × 100/1.3 NA, oil immersion objective.
Co-culture competition assay. B. ovatus DSM 1896 and R. intestinalis DSM 14610 were grown anaerobically in 20 ml YCFA supplemented with 0.5% (w/v) glucose to late-log phase, and an approximately equal number of cells (estimated by OD 600 ) were inoculated into CFA medium (YCFA lacking the yeast extract to minimize B. ovatus growth on yeast extract 53 ) containing 0.5% (w/v) WAX, BGX, InWAX or X4. The co-cultures were grown in triplicates and samples (2 ml) were taken during growth. In the propagation experiment, the co-culture was passaged into fresh media after 9 h of growth (start OD 600 = 0.01), then grown for 12 h and passaged again into fresh media and grown for 12 h. Genomic DNA was extracted from samples using DNAClean Microbial DNA isolation kit (Qiagen). Relative bacterial abundance was estimated by qPCR. The extracted DNA was diluted to 0.5 ng µ l −1 and amplified in technical triplicates using strain-specific primers (Supplementary Table 14 Relative bacterial concentrations were estimated by comparing gene copy numbers calculated using standard curves prepared with the respective reference DNA. Western blot was performed as described above but with cell cultures instead of purified proteins.
Life Sciences Reporting Summary. Further information on experimental design is available in the Life Sciences Reporting Summary.
Code availability. Adaptor trimming and demultiplexing was performed using custom python scripts (based on the Biopython SeqIO module 40 ) and the FASTXToolkitv0.0.13.2 (http://hannonlab.cshl.edu/fastx_toolkit/). The fastx_barcode_ splitter script (from FASTX-toolkit) was modified to demultiplex large fastq files provided from BGI. The modified version of this script is available upon request.
Data availability. The proteins characterized in this study are available from the NCBI with the following accession numbers: EEV01588.1 (ROSINTL182_06494), EEU99940.1 (ROSINTL182_08193), EEU99941.1 (ROSINTL182_08194), EEU99942.1 (ROSINTL182_08195), EEU99943.1 (ROSINTL182_08196), EEU99894.1 (ROSINTL182_08199) and EEU99897.1 (ROSINTL182_08202). The authors declare that the data supporting the findings of this study are available within the paper and the supplementary information or from the corresponding author on request. The fastx_barcode_splitter script (from the FASTX-toolkit) was modified to demultiplex large fastq files provided from the BGI. The modified version of this script is available upon request. 
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